Cheryl Rockman-Greenberg Selected Research

asfotase alfa

11/2021	Dental outcomes for children receiving asfotase alfa for hypophosphatasia.
11/2020	Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry.
1/2019	Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.
1/2019	Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
1/2019	Letter to the Editor: "Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study".
1/2016	Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
1/2016	Asfotase alfa therapy for children with hypophosphatasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cheryl Rockman-Greenberg Research Topics

Disease

12	Hypophosphatasia 01/2022 - 06/2013
3	Pain (Aches) 11/2020 - 01/2016
2	Infantile Hypophosphatasia 11/2021 - 01/2016
2	Kearns-Sayre Syndrome 01/2021 - 01/2021
2	Fabry Disease (Fabry's Disease) 01/2021 - 09/2020
2	Disease Progression 01/2020 - 02/2019
2	Congenital Abnormalities (Deformity) 02/2019 - 01/2016
2	Rickets (Rachitis) 01/2016 - 06/2013
1	Cytokine Release Syndrome 06/2022
1	Infections 06/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Dental Caries (Decay, Dental) 11/2020
1	Metabolic Diseases (Metabolic Disease) 11/2020
1	Dental Enamel Hypoplasia 11/2020
1	Stroke (Strokes) 10/2020
1	Mitochondrial encephalopathy 10/2020
1	Lactic Acidosis 10/2020
1	Leigh Disease (Leigh's Disease) 10/2020
1	MELAS Syndrome (Syndrome, MELAS) 10/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2020
1	Gaucher Disease (Gaucher's Disease) 01/2020
1	Failure to Thrive 02/2019
1	Medium chain acyl CoA dehydrogenase deficiency 01/2019
1	Injection Site Reaction 01/2019
1	Apnea 01/2018
1	Birth Weight (Birth Weights) 01/2018
1	Metabolic Bone Diseases (Osteopenia) 01/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2016
1	Muscle Weakness 01/2016
1	Muscular Diseases (Myopathy) 01/2016
1	Seizures (Absence Seizure) 06/2013
1	Nephrocalcinosis 06/2013
1	Osteomalacia 06/2013
1	Chronic Pain 06/2013
1	Hyperammonemia 12/2010
1	Obesity 12/2002
1	Acanthosis Nigricans 12/2002
1	Type 2 Diabetes Mellitus (MODY) 12/2002
1	Insulin Resistance 12/2002

Drug/Important Bio-Agent (IBA)

10	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2022 - 06/2013
7	Alkaline PhosphataseIBA 01/2022 - 06/2013
7	asfotase alfaIBA 11/2021 - 01/2016
3	Mitochondrial DNA (mtDNA)IBA 01/2021 - 10/2020
3	IsoenzymesIBA 01/2019 - 06/2013
2	Vitamin D FDA LinkGeneric 11/2020 - 01/2018
1	CytokinesIBA 06/2022
1	ametantrone (HAQ)IBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	EnzymesIBA 01/2019
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2019
1	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 01/2019
1	PyridoxalIBA 01/2019
1	Vitamin B 6IBA 01/2019
1	Caffeine (No Doz)FDA LinkGeneric 01/2018
1	DiureticsIBA 01/2018
1	SteroidsIBA 01/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	HHH syndromeIBA 12/2010
1	ornithine transporter (ornithine translocase)IBA 12/2010
1	Insulin (Novolin)FDA Link 12/2002
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 12/2002

Therapy/Procedure

7	Therapeutics 11/2021 - 01/2016
3	Enzyme Replacement Therapy 11/2021 - 03/2018
1	Orthopedic Procedures 02/2019
1	Length of Stay 01/2019
1	Duration of Therapy 01/2018